Literature DB >> 7657807

AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.

K Murakami-Mori1, T Taga, T Kishimoto, S Nakamura.   

Abstract

Oncostatin M (OM), which shares functional similarity and structural homology to leukemia inhibitory factor (LIF) and interleukin-6 (IL-6), functions as a potent growth factor for AIDS-associated Kaposi's sarcoma-derived cells (AIDS-KS cells). OM was also suggested to bind to the LIF receptor (LIF/OM receptor), which consists of a signal transducing subunit for LIF and IL-6 (gp130) and a LIF receptor alpha-subunit. Recent studies indicate that IL-6 has growth-stimulating activity for AIDS-KS cells. However, we find that AIDS-KS cell growth is exclusively induced by OM and not by LIF or IL-6. We also observed the lack of binding properties of AIDS-KS cells for LIF and IL-6. Scatchard plots revealed the existence of two affinity classes of OM receptor sites on AIDS-KS cells, with Kd values of 6-12 pM (high affinity) and 521-815 pM (low affinity). In competition binding studies, we find that the OM-specific receptor, but not the LIF/OM receptor, contributes to the OM-specific growth stimulation of AIDS-KS cells. We also noted that anti-gp130 antibodies can completely abolish OM-induced growth stimulation of AIDS-KS cells as well as OM binding to AIDS-KS cells. PCR amplification clearly revealed high levels of gp130 expression in AIDS-KS cells, while the transcript of LIF receptor alpha-subunit or IL-6 receptor alpha-subunit was not observed. Therefore, we conclude that (a) AIDS-KS cells express the OM-specific receptor with high and low affinity, but not the LIF/OM receptor; (b) gp130 on AIDS-KS cells plays a key role in OM binding and signaling on the OM-specific receptor; and (c) the lack of biological response of AIDS-KS cells to IL-6 and LIF can be explained by the absence of the IL-6 and LIF/OM receptors. All this evidence shows the correlation of OM-specific biological activity with expression of the OM-specific receptor and the involvement of gp130 on this receptor, as based on findings in in vitro growth assays and binding experiments for AIDS-KS cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7657807      PMCID: PMC185754          DOI: 10.1172/JCI118167

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130.

Authors:  T Taga; M Hibi; Y Hirata; K Yamasaki; K Yasukawa; T Matsuda; T Hirano; T Kishimoto
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

2.  Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells.

Authors:  T J Brown; M N Lioubin; H Marquardt
Journal:  J Immunol       Date:  1987-11-01       Impact factor: 5.422

3.  AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6.

Authors:  S A Miles; A R Rezai; J F Salazar-González; M Vander Meyden; R H Stevens; D M Logan; R T Mitsuyasu; T Taga; T Hirano; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

4.  Identification and characterization of cellular receptors for the growth regulator, oncostatin M.

Authors:  P S Linsley; M Bolton-Hanson; D Horn; N Malik; J C Kallestad; V Ochs; J M Zarling; M Shoyab
Journal:  J Biol Chem       Date:  1989-03-15       Impact factor: 5.157

5.  Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.

Authors:  S Nakamura; S Z Salahuddin; P Biberfeld; B Ensoli; P D Markham; F Wong-Staal; R C Gallo
Journal:  Science       Date:  1988-10-21       Impact factor: 47.728

6.  Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells.

Authors:  J M Zarling; M Shoyab; H Marquardt; M B Hanson; M N Lioubin; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

7.  Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M.

Authors:  N Malik; J C Kallestad; N L Gunderson; S D Austin; M G Neubauer; V Ochs; H Marquardt; J M Zarling; M Shoyab; C M Wei
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

8.  Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro.

Authors:  S Z Salahuddin; S Nakamura; P Biberfeld; M H Kaplan; P D Markham; L Larsson; R C Gallo
Journal:  Science       Date:  1988-10-21       Impact factor: 47.728

9.  AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects.

Authors:  B Ensoli; S Nakamura; S Z Salahuddin; P Biberfeld; L Larsson; B Beaver; F Wong-Staal; R C Gallo
Journal:  Science       Date:  1989-01-13       Impact factor: 47.728

10.  Receptors for T cell-replacing factor/interleukin 5. Specificity, quantitation, and its implication.

Authors:  S Mita; N Harada; S Naomi; Y Hitoshi; K Sakamoto; M Akagi; A Tominaga; K Takatsu
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

View more
  8 in total

1.  Contradictory Concepts in the Etiology and Regression of Kaposi's Sarcoma. The Ferenc Györkey Memorial Lecture.

Authors:  Joseph G Sinkovics
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

2.  Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow.

Authors:  S C Lin; T Yamate; Y Taguchi; V Z Borba; G Girasole; C A O'Brien; T Bellido; E Abe; S C Manolagas
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

3.  Interleukin-4 receptor expression on AIDS-associated Kaposi's sarcoma cells and their targeting by a chimeric protein comprised of circularly permuted interleukin-4 and Pseudomonas exotoxin.

Authors:  S R Husain; P Gill; R J Kreitman; I Pastan; R K Puri
Journal:  Mol Med       Date:  1997-05       Impact factor: 6.354

Review 4.  Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity?

Authors:  F Neipel; J C Albrecht; B Fleckenstein
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

5.  Human herpesvirus 8 encodes a homolog of interleukin-6.

Authors:  F Neipel; J C Albrecht; A Ensser; Y Q Huang; J J Li; A E Friedman-Kien; B Fleckenstein
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

6.  Kaposi's sarcoma-associated herpesvirus infection of endothelial cells inhibits neutrophil recruitment through an interleukin-6-dependent mechanism: a new paradigm for viral immune evasion.

Authors:  L M Butler; H C Jeffery; R L Wheat; P C Rae; K Townsend; K R Alkharsah; T F Schulz; G B Nash; D J Blackbourn
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

7.  Exclusive neutrophil recruitment with oncostatin M in a human system.

Authors:  S M Kerfoot; E Raharjo; M Ho; J Kaur; S Serirom; D M McCafferty; A R Burns; K D Patel; P Kubes
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

8.  Differential effects of oncostatin M and leukaemia inhibitory factor expression in astrocytoma cells.

Authors:  A Kasza; K Rogowski; W Kilarski; R Sobota; T Bernas; J Dobrucki; J Travis; A Koj; M Bugno; T Kordula
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.